A5094333293- Head and Neck Cancer Studies
- Brain Metastases and Treatment
- Cancer, Lipids, and Metabolism
- Prostate Cancer Diagnosis and Treatment
- Cancer Treatment and Pharmacology
- Breast Cancer Treatment Studies
- Lung Cancer Research Studies
- Prostate Cancer Treatment and Research
Sakarya University
2024-2025
ABSTRACT Objective The Prognostic Nutritional Index (PNI), reflects the nutritional and immunological status of patient has been associated with outcomes in various cancers. In this study, prognostic significance PNI metastatic hormone‐sensitive prostate cancer (mHSPC) its potential role guiding treatment decisions between abiraterone acetate enzalutamide is investigated. Methods Retrospective analysis was performed on 167 mHSPC patients treated 2019 2024. calculated using formula: 10 ×...
Objective: To determine the predictive factors for pathological complete response (pCR) in patients with non-ductal invasive breast cancer (ND-BC) receiving neoadjuvant chemotherapy.
Nasopharyngeal carcinoma (NPC) accounts for 0.01% of all carcinomas, and 70% patients have locally advanced disease with a poor prognosis. The mainstay therapy is chemoradiotherapy (CRT), concurrent administration platinum-based agents irradiation provides high local control rates. However, induction (neoadjuvant) chemotherapy (ICT) prior to CRT recommended large tumors tumor burden at the category 1 level. For ICT, doublet or triplet combination regimens are recommended. Selected time...